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Abstract
Background: Endoplasmic reticulum (ER) quality control mechanisms are part of a comprehensive system to manage cell
stress. The flux of molecules is monitored to retain folding intermediates and target misfolded molecules to ER-associated
degradation (ERAD) pathways. The mechanisms of sorting remain unclear. While some proteins are retained statically, the
classical model substrate CPY* is found in COPII transport vesicles, suggesting a retrieval mechanism for retention. However,
its management can be even more dynamic. If ERAD is saturated under stress, excess CPY* traffics to the vacuole for
degradation. These observations suggest that misfolded proteins might display different signals for their management.
Methodology/Principal Findings: Here, we report the existence of a functional ER exit signal in the pro-domain of CPY*.
Compromising its integrity causes ER retention through exclusion from COPII vesicles. The signal co-exists with other signals
used for retention and degradation. Physiologically, the export signal is important for stress tolerance. Disabling it converts
a benign protein into one that is intrinsically cytotoxic.
Conclusions/Significance: These data reveal the remarkable interplay between opposing signals embedded within ERAD
substrate molecules and the mechanisms that decipher them. Our findings demonstrate the diversity of mechanisms
deployed for protein quality control and maintenance of protein homeostasis.
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Introduction
Protein biosynthetic pathways are normally at equilibrium with
quality control mechanisms that monitor folding and assembly.
The small fraction of maturation failures are segregated and
delivered to degradative pathways like the ubiquitin-proteasome
system (UPS). Under severe stress, when the proportion of
unfolded proteins rises, the balance can shift to catabolism as a
prophylactic strategy against toxicity. In the endoplasmic reticu-
lum, these events are controlled by the unfolded protein response
(UPR) (for reviews, see [1,2]). In metazoans, the different outputs
of the UPR allow for a staged response with the initial phase to
favor restoration of folding capacity. If homeostasis is not restored,
a catabolic stage ensues [3]. In the budding yeast Saccharomyces
cerevisiae, the UPR is simpler and composed of the single, conserved
Ire1 output. Here, it is an inducible pathway that regulates nearly
400 genes [4]. All aspects of protein folding and maturation as well
as ER quality control are represented among these genes.
Interestingly, these represent but a small fraction of the targets.
The roles of many other functions regulated by the UPR remain
unknown.
ER quality control mechanisms play a key role in ER stress
tolerance. They monitor the folding states of newly synthesized
proteins. Unfolded proteins are retained in the ER and those
irreversibly misfolded are targeted to ER-associated degradation
(ERAD) pathways (for review, see [5–7]). ERAD pathways are
highly specialized mechanisms that incorporate the basic UPS at
their core. As with most UPS substrates the final destruction signal
is polyubiquitin, attached by specialized E3 ubiquitin ligase
complexes embedded in the ER membrane. In budding yeast,
the two known ERAD E3s, Hrd1p and Doa10p, modify distinct
substrate classes. The Doa10p complex ubiquitinates membrane
proteins with malformed cytosolic domains and soluble cytosolic
proteins bearing specific destruction signals (8–11). The larger
Hrd1p complex ubiquitinates proteins bearing transmembrane
lesions and also damaged lumen-localized proteins/domains
[8,11–14]. All substrates are extracted from the ER by the
associated Cdc48 complex before degradation by the 26S
proteasome.
It is widely accepted that ERAD substrates are recognized and
processed by ER receptor sites. However, it is also known that
some molecules traffic to the Golgi before they are retrieved for
ERAD [15–17]. Before degradation, N-linked oligosaccharides are
released by the cytosolic peptide:N-glycanase (PNGase or Png1p)
[18,19]. These free oligosaccharides provide a biochemical record
of endogenous substrates processed by ERAD-L (L, luminal).
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show that a significant fraction was modified by the Golgi
mannosyltransferase Och1p [20]. This analysis provides compel-
ling evidence that substrate transport and retrieval is not restricted
to models but a common mechanism of ERAD. Blocking these
activities using yeast mutants also disrupts substrate degradation,
suggesting a role in ERAD [15,16]. However, it was proposed that
the observed defects could be an indirect consequence of the
particular mutant strains used [21]. Thus, whether the retrieval
mechanism used by some substrates is also required for their
ERAD remains unresolved.
Although some misfolded luminal proteins recycle between the
ER and Golgi prior to ERAD, these can be diverted to the
vacuole under conditions of severe stress [22]. The UPR
regulates components of this pathway, which includes membrane
trafficking mediators as well as vacuolar proteases [4]. Whether
the ER-to-vacuole pathway is an essential facet of ER stress
tolerance is not clear. Some evidence comes from strains lacking
the cargo sorting receptor Erv29p. ERV29 mutants cannot
transport misfolded proteins and exhibit sensitivity to ER stress
[15,22]. On the other hand, they are also defective in the export
of some normal proteins, which might indirectly compromise
stress tolerance [23]. Thus, even as the trafficking of misfolded
proteins through the endomembrane system is well documented,
its physiological role is unclear and its underlying mechanisms
relatively unexplored.
Two recent studies specifically explored the role of export
signals in ER quality control. To determine the effect of a powerful
ER export signal on the processing of a misfolded protein, Kincaid
and Cooper engineered novel versions of CPY* fused to the
transmembrane and cytosolic domains of Sys1p [24]. The Sys1p
cytosolic domain contains a well-characterized diacidic motif
export signal recognized by the Sec23/24 proteins of the COPII
complex [25,26]. Interestingly, the chimeric protein was efficiently
transported from the ER, demonstrating that the strong Sys1p
export signal could override the retention of CPY* by ER quality
control. Transport was dependent on the export signal since its
alteration caused the chimera to be retained. Adopting a different
approach, Miller and coworkers studied the quality control of
misfolded Yor1p (called Yor1p-DF), a homolog to the cystic
fibrosis transmembrane conductance regulator [27]. Like the
CPY*/Sys1p chimera, Yor1p sorting into COPII vesicles is
dependent on a cytoplasmic diacidic motif. However, Yor1p-DF
is retained in the ER, even when ERAD was blocked. Unresolved
from these studies is whether embedded export signals are
functional when the proteins are unfolded. A conformational
requirement for the formation of ER export signals can underlie a
workable retention mechanism for ER quality control. This
mechanism may be in place for some proteins [28,29]. Although
appealing for its simplicity, it is certainly not a general mechanism
for all molecules because there is clear evidence that some
misfolded proteins traffic from the ER in COPII vesicles
[22,24,30–34].
In this study, we examined the interplay between export
signals and opposing retention/ERAD signals using the classical
model substrate CPY*, a soluble luminal protein [35]. We
determined that CPY could display both types of signals when
misfolded. The export signal is not required for ERAD, which is
sufficient to handle the protein load under low stress conditions.
However, under severe stress, the export signal becomes an
essential element to divert excess substrate to the UPR-regulated
ER-to-vacuole degradative pathway. CPY* variants lacking their
export signal are toxic due to their inability to utilize the
alternative pathway.
Results
The model misfolded protein CPY* contains a functional
ER exit signal
We sought to understand the mechanism and physiological
significance of misfolded protein export from the ER. Previously,
this phenomenon was studied using transport defective mutant
strains [15,16,21]. However, indirect effects caused by impairment
of normal cargo proteins could not be ruled out [21]. This
drawback could be mitigated by modifying substrates to disable
transport. To test the feasibility of the approach, CPY* deletion
variants were created systematically to eliminate a potential export
signal (Fig. 1A). It should be noted that no ER export signal is
known for CPY* nor even wild type CPY. To facilitate analysis, all
constructs contain an HA epitope-tag at their carboxy-termini,
which does not affect ERAD nor transport [22]. In addition, the
C-terminal glycan of CPY* (previously termed the ‘‘D-glycan’’) is
maintained in all variants because it is required for recognition by
ERAD [36].
We combined in vitro and in vivo approaches to analyze COPII
vesicle packaging and vacuolar transport of CPY* variants,
respectively. At moderate expression levels, CPY* is efficiently
degraded by ERAD, with some molecules packaged into COPII
vesicles and retrieved from the Golgi beforehand [16]. Expression
of CPY* under the control of the strong GAL1 promoter saturates
ERAD and activates the UPR [22]. The UPR controls the ER-to-
vacuole transport pathway, which is used to dispose excess CPY*
under these conditions. Consistent with our previous observations,
indirect immunofluorescence confocal imaging localizes CPY* to
the ER of wild type cells (Figure 1B, upper panels). Vacuolar
staining is absent because of rapid substrate degradation there. To
visualize the fraction that traffics to the vacuole, substrates were
also expressed in the vacuolar protease deficient Dpep4 strain.
Here, CPY* is detected strongly in compartments outside the ER
that were previously determined to be vacuoles (Figure 1B, lower
panels) [22]. All CPY* deletion variants display a similar pattern,
except two (Figures 1C and S1). The CPY*-D1 and CPY*-D2
variants exhibited no detectable extra-endoplasmic reticulum
staining indicating defects in ER export. In line with this view,
the steady state levels of these substrates are significantly higher
than CPY* and other variants in wild type cells (Figure S3A).
Indeed, in pulse chase experiments, CPY*-D1 and CPY*-D2
constructs are stable proteins in wild type cells with no further
stabilization in Dpep4 cells (Figure 2). This result contrasts with
transport competent CPY*, where a fraction is degraded by
ERAD in Dpep4 cells (Figure 2A) [22]. Because the portions
deleted in CPY*-D1 and CPY*-D2 are not required for ERAD
when moderately expressed [46], the data suggest that transport-
defective CPY* variants can interfere with ERAD functions if
highly expressed.
We next sought to determine how loss of the D1 and D2
segments disrupt CPY* trafficking. The simplest explanation posits
that elements contained within them are required for ER export.
Alternatively, the deletions might disrupt a vacuolar sorting signal
resulting in secretion and/or retrieval of substrates. Pulse-chase
analysis is consistent with the first scenario. Compared with CPY*,
the D1 and D2 variants displayed little of the heterogeneous outer
chain glycosylation characteristic of CPY* molecules trafficking
through the Golgi (Figure 2, ‘‘hyperglycosylated’’ forms) [22]. To
address the question directly, we applied an in vitro assay to test the
packaging of CPY* variants into COPII vesicles. Semi-intact cells
were prepared from wild-type strains expressing the appropriate
CPY* variant. To initiate the reaction, cytosol from wild-type
yeast cells and recombinant Sar1p were added along with GTP,
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vesicles were recovered in the supernatant fraction, purified, and
concentrated. Recovery of Erv25p (a constituent of COPII
vesicles) in the vesicle fraction in the defined system and absent
from control membranes demonstrates the efficacy of the assay
(Average packaging efficiency, 8.9%. Figure S2A). Similarly,
CPY* and the D3 through D6 variants can be packaged into
COPII vesicles (Figures 3A and S2A). Likely due to high substrate
levels, packaging efficiency of CPY*/variants was modest, yet
nevertheless similar to previous studies using a purified microsome
system [16]. By contrast, CPY*-D1 and CPY*-D2 variants were
largely absent in the budded vesicle fraction (Figure 3A). These
data provide an independent line of evidence that traces their
transport defect to the ER vesicle budding step. To determine if
Figure 1. Analysis of CPY* export signals. (A) Schematic representation of CPY* and its deletion variants (D1–D6). Carbohydrate chains are
shown by branched symbols, asterisks indicate the position of the G255R mutation, dark shaded boxes indicate signal sequences, and the HA epitope
tag is shaded light gray. (B) Intracellular localization of highly expressed CPY* deletion variants in wild type and Dpep4 strains. CPY* variants was
detected using anti-HA antibody and visualized in the green channel. ER and nuclear envelope was visualized in the red channel using anti-Kar2p
antiserum. (C) Intracellular localization of D1 and D2 variants in Dpep4 cells. Substrates and ER/nuclei are visualized as in panel B. Localization of all
CPY* deletion variants in both wild type and Dpep4 cells are shown in Figure S1. Arrowhead indicates the accumulated CPY* or its variant in vacuole
in a representative cell. Scale bars, 5 mm.
doi:10.1371/journal.pone.0015532.g001
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transport of the plasma membrane protein Gas1p was analyzed
following their induction [38]. As shown in Figure 3B, Gas1p is
transported from the ER efficiently in all situations after substrate
induction indicating that the variants do not generally affect
protein trafficking. These data show that the D1 and D2 lesions
prevent the trafficking of excess CPY* to the vacuole through
selective exclusion from COPII vesicles. The transport defects
indicate that an ER export signal(s) was compromised by the D1
and D2 deletions.
Cell death caused by highly expressed CPY* in IRE1 or ERV29
mutants suggested that misfolded protein accumulation in the ER,
if left unchecked, is toxic [22,39]. However, it was unclear whether
CPY* accumulation was the sole cause of death or if decreased
fitness caused by null mutations also contributed. With export
deficient CPY* variants, it is now possible to answer this question
directly without using genetically compromised cells. For this, we
induced CPY* and variant expression in wild type cells. As shown
in Figure 3C (+Glc), all strains grew well on glucose media which
represses expression of the misfolded proteins. A different pattern
emerged following induction on galactose media. Cells highly
expressing CPY* grew well as previously reported [22]. Variants
D3 through D6 exhibited no inhibition compared with full-length
CPY*. By contrast, the growth of cells expressing CPY*-D1 and
CPY*-D2 was strongly inhibited (Figure 3C, rows D1 and D2).
Strikingly, Dcue1 and Dhrd1 cells (required for luminal ERAD [40–
42]) grew well when expressing CPY* and transport competent
variants (Figure S4, +Gal panel). This result shows that availability
of the ER-to-vacuole degradative pathway alone can alleviate their
toxicity. As expected, expression of transport-deficient variants was
toxic to these cells. These data show that the potential toxicity of
misfolded CPY is mitigated by a functional ER export signal in the
unfolded molecule. Without the ability to exit the ER, misfolded
variants become toxic even in wild type cells. This finding provides
a physiological basis for the existence of functional ER export
signals in misfolded proteins.
N-linked glycans are required for CPY* trafficking
We wondered what features of the deleted sequences are
required for export. The D1 lesion removed the pro-domain of
CPY but left the mature portion intact. This finding was
particularly exciting because another Erv29p-dependent cargo
protein, folded glycopro-a factor, contains its ER export signal in
the pro-domain [43]. Although the pro-domain is required, it may
not be sufficient because the D2 deletion also blocks transport.
Unlike the deleted D1 sequences, the deleted segment of CPY*-D2
is normally modified by two N-linked glyans in full length CPY*
(Figure 1A). Because N-linked glycosylation is required for the
transport of some proteins [44], we analyzed the contribution of
three glycans not involved in ERAD signaling (Figure 1A: glycans
A, B, and C) systematically.
By site-directed mutagenesis, the three glycosylation sites were
eliminated singly (lower case letters indicate mutated sites: aBCD-
CPY*, AbCD-CPY*, and ABcD-CPY*), doubly (abCD-CPY*,
aBcD-CPY*, and AbcD-CPY*), or together (abcD-CPY*, previ-
ously constructed (36)). Expression was induced with galactose and
each variant was localized by indirect immunofluorescence in wild
type and Dpep4 cells (Figure 4). Like CPY*, single glycan mutants
were found in vacuolar compartments indicating that no single
glycan is essential for export (Figure 4, upper 3 rows). The AbCD-
CPY* variant showed greater ER staining than the others
suggesting that the B glyan might contribute most significantly
to ER exit (Figure 4, compare panel i3 to h3 and j3). Among
double mutants, the strong vacuolar localization of the aBcD-
CPY* confirms the importance of the B-glycan (Figure 4, compare
panel l3 to k3 and m3). AbcD-CPY* localized to vacuolar
compartments but much more weakly than aBcD-CPY* (Figure 4,
compare panels l3 and k3). With abCD-CPY*, however, no
vacuolar localization could be detected. These data indicate that
the A and B glycans, eliminated in the D2 variant, are essential for
vacuolar transport. Accordingly, the abcD-CPY* variant was
localized exclusively to the ER (Figure 4, panels n1 to n3).
To analyze further the role of the A, B, and C glycans in CPY*
transport, COPII vesicle budding assays were performed on
aBCD-CPY*, AbCD-CPY*, abCD-CPY*, and abcD-CPY*
(Figure 5A and S2B). Single glycosylation mutants packaged into
COPII vesicles to an extent similar to fully glycosylated CPY*
(compare Figure 5A with Figure 3A). The abCD-CPY* variant
was packaged less efficiently and the variant lacking all three sites
was undetected in the vesicle fraction (Figure 5A). Although the
trend is in good agreement with localization studies, the
requirements for CPY* vesicle budding in vitro are less stringent
for the presence of individual glycans. To reconcile these
differences, we analyzed the effects of glycan site mutations by
pulse-chase analysis in Dpep4 cells, which do not impede transport
but do prevent vacuolar degradation. We adapted this in vivo assay
to measure transport by monitoring conversion to the heteroge-
neous migrating forms, a measure of transport through the Golgi.
Using this approach, abCD-CPY* converted forms were not
detected indicating a block in ER-to-Golgi transport (Figure 5B).
For the single mutants, aBCD-CPY* and ABcD-CPY* mutants
were converted relatively efficiently with AbCD-CPY* falling
somewhere in between. Taken together, these data show that N-
linked glycans are required for CPY* ER export with glycan B
being the most important.
To determine further whether transport efficiency correlated
with toxicity, CPY* glycosylation mutants were expressed in wild
type cells by galactose induction. Here, cells challenged with
single-glycan mutants grew no worse than control (Figure 5C). By
contrast, the transport defective abCD-CY* and abcD-CPY*
variants caused strong growth inhibition. The slightly stronger
inhibition caused by abcD-CPY* supports the idea that the C
glycan can also contribute to transport. Importantly, Western
analysis shows much greater steady state levels of these variants in
wild type cells compared with transport competent variants (Figure
S3B). Unlike CPY* deletion variants, these have equal lengths and
differed primarily by glycan occupancy. These data strengthen the
conclusion that the ability of substrates to use the ER-to-vacuole
pathway reduces their intrinsic toxicity.
Transport and retrieval are not prerequisites for ERAD
CPY*, expressed at moderate levels from its native promoter, is
degraded exclusively by ERAD [45]. Under these conditions,
some molecules are packaged into COPII vesicles indicating that
Figure 2. CPY* variants D1 and D2 are degradation defective. Wild type and Dpep4 cells expressing CPY* and variants following galactose
induction were pulse-labeled for 10 min with [
35S]methionine/cysteine and chased for times indicated. Substrate proteins were immunoprecipitated
from detergent lysates, separated by SDS-PAGE, and visualized and quantified by phosphorimager analysis. Representative gel scans are shown on
the left. The position of substrate proteins and hyperglycosylated species are indicated. Data plots reflect three independent experiments with
standard deviations indicated by the error bars.
doi:10.1371/journal.pone.0015532.g002
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15532Figure 3. ER transport deficient CPY* variants are cytotoxic. (A) D1 and D2 variants are defective in ER vesicle budding. In vitro vesicle
budding assays were performed using permeabilized cells from wild-type cells highly expressing CPY* and deletion variants. Total membranes and
budded vesicles (Figure S2. ‘‘Sup’’) were collected from each reaction containing cytosol/Sar1p or buffer only. Cargo packaging efficiency was
analyzed by immunoblotting and quantified using the LI-COR fluorescence imaging system. A representative fluorograph is shown in Figure S2.
Detection of the endogenous COPII vesicle protein, Erv25p, was included as a positive control. Three independent assays were performed for each
experiment with error bars reflecting the standard deviation. Statistical significance was determined using Student’s paired t-test (D1 or D2 vs. CPY*
control, p,0.01). (B) Expression of D1 and D2 variants do not cause a general block in transport from the ER. Wild-type cells highly expressing CPY*
and the D1 and D2 variants were pulse-labeled for 10 min with [
35S]methionine/cysteine and chased for the indicated times. Endogenous Gas1p was
immunoprecipitated from detergent lysate, separated by SDS-PAGE, and visualized by phosphorimaging. (C) Wild-type cells highly expressing CPY*
or its variants were grown overnight in culture medium with 3% raffinose (pre-induction). Cells were spotted on SC plates containing 2% glucose (Glc,
repressed) or 2% galactose (Gal, induced) as serial dilutions of each cell culture. Plates were incubated for 2 days at 30uC.
doi:10.1371/journal.pone.0015532.g003
ER Export Signals in Stress Tolerance
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15532they are degraded after their retrieval from the Golgi apparatus
[16]. The stabilization of CPY* in COPII and COPI vesicle
transport mutants suggested that trafficking might be a require-
ment for its degradation [15,16]. However, it was proposed that
the strong stabilization observed might be due to secondary effects
of the transport mutants on ERAD [21]. The CPY*-D1 and
CPY*-D2 variants can be used to resolve this issue because they
carry the CPY ERAD determinant and are unable to exit via the
COPII pathway [46]. To determine if transport and retrieval is
coincidental or a requirement for ERAD, the D1, D2, and D3
Figure 4. N-glycans are required for for CPY* vacuolar transport. Wild type and Dpep4 cells carrying CPY* and its glycosylation variant genes
(wild type glycan sites are denoted in upper case, mutant sites in lower case) were induced for 6 hr. Intracellular localization of proteins were
performed by indirect immunofluorescence as in Figure 1. Arrowheads indicate vacuolar forms of induced proteins. Scale bars, 5 mm.
doi:10.1371/journal.pone.0015532.g004
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promoter and turnover was analyzed by cycloheximide chase
and immunoblotting. The CPY* control is degraded rapidly in
wild type cells and stabilized in the Dcue1 ERAD mutant as
expected (Figure 6, upper left). The transport competent CPY*-D3
variant behaves identically showing that a large internal deletion
has no effect on degradation as long as its ERAD determinant is
present (Figure 6, lower right). Applying the same assay to CPY*-
D1 and CPY*-D2, their turnover profile is identical to CPY*.
These data show that substrate transport and retrieval are not
requirements for ERAD. Instead, the observed transport and
retrieval of misfolded proteins likely reflects a mechanism of ER
retention, analogous to that of ER resident proteins bearing C-
terminal HDEL retention sequences [47].
Figure 5. Glycans A and B are required for ER export. (A) Wild-type cells highly expressing aBCD-CPY*, AbCD-CPY*, abCD-CPY*, and abcD-CPY*
were used in in vitro vesicle budding assays as described in Figure 3. Each data set is from three independent experiments with the standard
deviation represented by error bars. Statistical significance was determined using Student’s paired t-test (aBCD-CPY*, AbCD-CPY*, or abCD-CPY* vs.
abcD-CPY*, p,0.05). (B) Dpep4 cells highly expressing glycan variants in panel A were pulse-labeled for 10 min with [
35S]methionine/cysteine and
chased as indicated. Substrate proteins were immunoprecipitated, separated by SDS-PAGE, and visualized by phosphorimaging. The position of
hyperglycosylated forms is indicated. (C) Transport deficient glycan variants are toxic. Wild type cells carrying CPY* (ABCD) and glycan variant genes
were assayed for cytotoxicity following induction as described in Figure 3C.
doi:10.1371/journal.pone.0015532.g005
ER Export Signals in Stress Tolerance
PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e15532Discussion
Proteins exported out of the ER are concentrated into COPII-
coated vesicles through interactions with cargo sorting receptors.
Export signals include diacidic or dihydrophobic motifs located in
the cytoplasmic domains of some membrane proteins. These are
recognized by the Sec23/24 subunits of the COPII complex
[25,26]. Physically separated from coat components, soluble cargo
proteins are sorted by binding various export receptors in the ER
lumen [48]. Although not as well characterized, soluble cargo
proteins including procathepsin Z and alkaline phosphatase
contain export signals that are functional only when folded
[28,29]. These findings led to proposals that the formation of ER
export signal dependent on polypeptide folding could be a general
mechanism of ER quality control. However, evidence that some
molecules can efficiently traffic in the absence of positive acting
export signals has challenged this view [49].
In this study, we demonstrated that the classical ERAD
substrate CPY* contains determinants for ER export that
encompass the pro domain and at least one nearby glycan.
Although our data do not rule out a local conformational
component to the signal, its ability to function does not depend
on the correct overall structure of the protein. Importantly, the
export signal does not subvert ERAD. Instead, the presence of
chaperone binding sites and positive ERAD signals are sufficient to
retain and degrade CPY* [46]. In this way, CPY* differs from the
transmembrane protein Wsc1p, which contains a powerful ER
export signal in its cytoplasmic domain. When its luminal domain
misfolds, the lack of an ERAD degradation/retention signal makes
it dependent on a post-ER mechanism for quality control [30].
During times of stress, however, CPY*’s ER export signal allows it
to bypass ERAD and use the ER-to-vacuole pathway for turnover
[22].
T h eA ,B ,a n dCg l y c a n sc o n t r i b u t et oC P Y *E Re x p o r t ,w i t h
the B glycan being the most important. Currently, their role is
unclear. By analogy to glycan-dependent ERAD, the signal
could be bipartite, combining pro-domain sequences and a
glycan for recognition by an unknown lectin-like cargo receptor
[46]. Alternatively, because the glycans can substitute for each
other, they may instead play a structural role that promotes
CPY* solubility. Along a similar line, these glycans could
contribute to the folding of a conformational export signal. In
this scenario, the glycans are not part of a signal but contribute to
its formation. Glycans are not just important for the export of
misfolded CPY. A detailed study of CPY N-linked carbohydrates
revealed that the B-glycan is critical for transport of the folded
molecule. An AbCD-CPY variant is transport deficient while a
variant carrying just the B glycan is transported efficiently [50].
The D glycan on the other hand, required for ERAD of
misfolded CPY, is entirely dispensable for transport and
enzymatic activity. These studies demonstrate the diversity of
functions of individual N-linked glycans of CPY for biogenesis,
transport, and quality control.
High-level expression of CPY* is highly toxic to transport-
deficient strains but it does not affect the apparent fitness of wild-
type cells [22,39]. CPY* accumulation in Derv29 cells resulted in
the generation of reactive oxygen species that likely contributes to
cell death [39]. Erv29p is a COPII vesicle cargo sorting receptor
that is required to package a number of endogenous folded
proteins including proCPY and pro-a factor [23]. To what extent
the general trafficking block contributed to the observed
phenotype is unknown. In this study, disabling the CPY* ER
export signal converted a well-tolerated protein to one that is toxic.
This difference pinpoints the nature of the proteotoxcity and
leaves no doubt that the ER accumulation of an ERAD substrate,
beyond a certain threshold, is highly toxic. Our data show that the
functional export signal in misfolded CPY contributes to ER stress
tolerance by allowing it to use the vacuolar pathway. Whether
functional export signals are generally found in misfolded proteins
is not known.
The ER-to-vacuole pathway is well suited for a role in stress
tolerance because it has a greater substrate capacity than ERAD
[22]. Recent reports have revealed the vacuole/lysosome plays a
major constitutive role in the disposal of aberrant proteins. Protein
aggregates in the cytosol and ER are delivered to the vacuole/
lysosome using autophagic pathways [51–53]. Some misfolded
proteins that evade ER quality control are transported the vacuole
using the classical secretory pathway [22,30–34,54]. The studies
show that the vacuole/lysosome system is at least an equal partner
to the UPS in the disposal of aberrant proteins.
Figure 6. Export deficient mutants are efficiently degraded by ERAD. CPY* and the D1, D2, and D3 variants were moderately expressed
under the control of its native promoter in wild type or Dcue1 cells. Equal cell numbers were harvested at the indicated times after the addition of
cycloheximide (100 mg/ml) and detergent lysates prepared. Proteins were separated by SDS-PAGE and detected by immunoblotting. Quantification
was performed using an Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE). Endogenous Sec61p was detected from the same filters
as a loading control.
doi:10.1371/journal.pone.0015532.g006
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moderately expressed. This shows that trafficking between the
compartments is not a prerequisite for ERAD. Why then, do some
CPY* molecules traffic to the Golgi before ERAD? Our data show
that CPY* can display signals for both COPII-mediated export
and ERAD. Efficient degradation of transport-defective CPY*
shows that ER export and ERAD are not obligatorily sequential
steps, but kinetically competitive processes. Thus, substrate
retrieval from the Golgi might simply reflect an ER retention
mechanism similar to proteins carrying C-terminal HDEL signals
[47]. Indeed, the CPY* ERAD determinant is a binding site for
Kar2p/BiP [46], an HDEL-bearing ER chaperone [55,56]. Thus,
the presence of functional ER export signals makes a retrieval
mechanism essential for the ERAD of molecules bearing them.
Recent findings from the Suzuki laboratory suggest that the
trafficking of misfolded proteins to the Golgi might play a more
active role in ERAD. An analysis of free cytosolic oligosaccharides
(released from endogenous ERAD substrates by PNGase) showed
a low abundance of GlcNAc2Man7 glycans [20]. This is significant
because the glycoform is generated by Htm1p, a mannosidase
whose activity exposes a terminal a1,6-linked mannose that serves
as a ligand for the ERAD factor Yos9p [57,58]. Surprisingly, a
much larger proportion of free oligosaccharides also bears the
potential Yos9p ligand but generated instead by the Golgi
localized Och1p mannosyltransferase. This raises the exciting
possibility that Och1p functions analogously to Htm1p. In this
mode, misfolded glycoproteins that traffic to the Golgi would
receive terminal a1,6-linked mannose signal before their return to
the ER for ERAD.
In summary, our studies using the classical ERAD model
substrate CPY* show that functional ER export signals coexist
with ERAD/retention signals. Remarkably, these signals are
interpreted by the quality control machinery to use the ERAD
pathway under normal conditions. Under ER stress, concomitant
with increasing misfolded protein concentrations and UPR
activation, these signals are used to detoxification by diverting
the molecules to the vacuole.
Materials and Methods
Plasmids
Plasmids used in this study are listed in Table 1 and were
constructed using standard cloning protocols [59]. All plasmid
inserts were confirmed by DNA sequence analysis. pDN436
encodes CPY*-HA under the control of PRC1 promoter [60]. A
CPY*-HA deletion series was constructed as described below. D1,
D2, D3, D4, D5, and D6 variants lack amino acid residues 25–
112, 113–200, 201–303, 304–400, 389–476, and 482–532 of
CPY*-HA, respectively.
pAS63, pAS64. For each plasmid, a fragment containing the
N-terminal coding sequences of CPY* behind the PRC1 promoter
was amplified by PCR using Vent DNA Polymerase (New
England Biolabs, Ipswich, MA) with pDN436 as a template and
cleaved with EagI. The sequences encoding the C-terminal region
of CPY* was similarly amplified and cleaved with XbaI. The
phosphorylated fragments were ligated into the EagI/XbaI sites of
pRS315 to generate each plasmid. PCR primers were designed to
precisely delete defined sequences after ligation into plasmids.
pAS67. Constructed as described in the preceding section
except amplified products encoding CPY*-HA C-terminal
sequences were digested with SalI. The fragments encoding the
N- and C-termini were ligated into the EagI/SalI sites of pRS316
to complete the deletion construct.
pES28. HA epitope-tagged CPY* behind the control of the
GAL1 promoter and inserted in YCp50 was previously described
[22].
pSK88, pSK89, pSK90, pSK91, pSK93. CPY*-HA deletion
variant coding sequences were amplified by PCR using pAS67,
pAS63, pAS64, pAS77, or pAS68 as templates. Fragments were
ligated directly into the T/A-cloning site of pYES2.1 vector
containing GAL1 promoter. These constructs were cleaved with
AgeI and SphI. DNA fragment containing GAL1 promoter and
CPY* deletion was ligated into AgeI/SphI sites of the YCp50-based
pTS210 vector [61].
pSK92. The GAL1 promoter regulated CPY* variant D5 was
created by deleting the coding region for 389–476 residues of
CPY* via site-directed mutagenesis using pES28 as a template
[62].
pSK95, pSK96, pSK97. The plasmids encoding the single
glycosylation mutants aBCD-CPY*, AbCD-CPY*, and ABcD-
CPY* in pRS315 were described previously [36]. The coding
sequences of each variant was amplified by PCR and ligated
directly into T/A-cloning site of pYES2.1 vector. The genes now
behind the GAL1 promoter were cleaved with AgeI and SphI and
ligated into same sites in pTS210.
pCH66. The GAL1 promoter regulated HA-tagged
abcDCPY* vector, was constructed by digesting pES147 [36]
with AccI, followed by treatment with T4 DNA polymerase and
digestion with SphI. The released insert was ligated into BamHI (T4
DNAP-treated)/SphI-digested pTS210 [61].
pSK94, pSK103, pSK104. The plasmids for abCD-CPY*,
AbcD-CPY*, and aBcD-CPY* were created via PCR-based
mutagenesis using the pCH66 as a template by mutating codons
encoding Asn to Gln in the corresponding N-glycosylation sites.
Strains and antibodies
Saccharomyces cerevisiae strains used in this study are described in
Table 2. Anti-HA monoclonal antibody (HA.11) was purchased
from Covance Research Products (Richmond, CA). Anti-Kar2p
and anti-Sec61p rabbit antisera were provided by Dr. Peter Walter
(University of California, San Francisco, CA). Anti-Gas1p rabbit
antiserum was previously described [22]. Anti-Erv25p antibody
was a gift from Dr. Charlie Barlowe (Dartmouth College Medical
School, Hanover, NH).
Substrate induction and metabolic pulse-chase
Cells carrying GAL1 promoter regulated CPY* and its variants
were grown at 30uC in synthetic complete (SC+3% raffinose)
media lacking the appropriate amino acids to mid-logarithmic
phase. To initiate expression, cells were pelleted by low speed
centrifugation, the supernatant discarded, and resuspended in
fresh media containing 2% galactose. Cells were then grown for
6 h at 30uC before processing. Cell labeling, preparation of
detergent lysates, and immunoprecipitation were carried out as
described previously [16].
Cycloheximide chase assay
Cells are grown as described in figure legends. To begin the
chase, protein synthesis is terminated by adding cycloheximide to
the culture media (100 mg/ml final) with continued incubation at
30uC. At specified time points, cells were collected and a tenth
volume of ice-cold 100% trichloroacetic acid (TCA) added to end
the chase. Cells were disrupted using 0.5 mm zirconium beads in a
Mini Beadbeater-8 homogenizer at 2630 s cycles (BioSpec
Products Inc., Bartlesville, OK). TCA precipitates were collected
by centrifugation and detergent lysates were prepared as described
previously [16]. Proteins were separated by SDS-PAGE and
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incubated with appropriate primary antibodies for 1 h at room
temperature. Membranes were washed in phosphate buffered
saline containing 0.1% Tween 20 and further incubated with
secondary antibodies labeled with infrared dye, IRDye 680 or
IRDye 800. Fluorescence was detected and quantified by using the
Odyssey infrared imaging system (LI-COR Biosciences, Lincoln,
NE).
COPII vesicle budding assay using semi-intact cells
Permeabilized cell-based vesicle budding assays were performed
as described previously [37] with some modifications. Galactose-
activated CPY* and variants were spheroplasted and gently frozen
at 280uC. Next, the frozen spheroplasts were gently thawed on ice
and treated with 2.5 M Urea in B88 (20 mM HEPES/KOH,
pH 6.8, 150 mM KOAc, 5 mM MgOAc, and 250 mM sorbitol)
on ice for 5 min and washed with B88. Budding reactions (total
150 ml) contained 30 ml of the permeabilized cell membranes
(from ,3O D 600 cells), 300 mg crude cytosol, 3 mg the recombi-
nant Sar1p, ATP mix (1 mM ATP, 40 mM creatine phosphate,
and 0.2 mg/ml creatine phosphokinease in B88), 0.2 mM GTP,
and 25 mM GDP-mannose. A fraction of each reaction mixture
was saved as a control (total fraction). Reaction mixes were
incubated at 30uC for 90 min and centrifuged at 14,000 rpm at
4uC for 2 min to separate budded vesicles. The vesicle fraction was
further purified by a density step gradient as described previously
[63] with following modifications. 125 ml of supernatant was
transferred to a TLS-55 ultracentrifuge tube (Beckman Coulter,
Brea, CA) and mixed with the same volume of B88. 250 ml of 70%
w/v Nycodenz (Sigma-Aldrich, St. Louis, MO) in B88 was added
and mixed. 500 ml each of 30%, 25%, and 15% Nycodenz in B88
were layered. The gradient was centrifuged at 50,000 rpm for 2 hr
at 4uC. 100 ml from the top was discarded and the next 800 ml was
placed in a new TLS-55 tube. Sample was diluted by adding equal
volume of B88 and centrifuged again at 34,000 rpm for 1 hr at
4uC. After removal of all supernatant, membrane pellet was
dissolved 31 ml of sample loading buffer for SDS-PAGE analysis
(budded vesicle fraction). Protein detection and quantification
were performed as described above by using the Odyssey infrared
imaging system (LI-COR Biosciences, Lincoln, NE).
Indirect immunofluorscence microscopy
Indirect immunofluorescence was performed as described
previously [22]. Briefly, cells were fixed with 3.7% formaldehyde
at 30uC for 90 min and spheroplasted by treating with 1 mg/ml
zymolyase 20 T (United States Biological Inc., Marblehead, MA)
in a 50 mM potassium phosphate buffer, pH 7.5 containing 1.4 M
sorbitol for 20 min at room temperature. A cell suspension was
applied to each well of a poly-L-lysine-coated slide for 10 min and
the unbound cells were washed out. Slides were immersed in
methanol for 6 min and in acetone for 30 sec at 220uC. Each well
was blocked with TBS (50 mM Tris-Cl, pH 7.4, 150 mM NaCl)
containing 0.05% Tween-20 and 5% non-fat dry milk. Primary
antibodies and secondary antibodies were applied with appropri-
ate dilution and incubated for 90 min each time. Slides were
washed twice with TBS buffer after each application. Working
concentrations of primary antibodies HA.11 mAb (Covance
Research Products, Princeton, NJ) and polyclonal anti-Kar2p
were 1:200 and 1:500 respectively. Secondary antiboldies Alexa
Fluor 488 goat anti-mouse and Alexa Fluor 596 goat anti-rabbit
(Molecular Probes, Inc., Eugene, OR) were diluted to 1:500.
Confocal images were obtained with Zeiss Axiovert 200 M
microscope equipped with 100x 1.4NA oil Plan-Aprochromat
objective (Carl Zeiss MicroImaging, Inc., Oberkochen, Germany).
Images were archived by LSM Image Browser.
Table 1. Plasmids used in this study.
Plasmid Protein Carbohydrate Modification Promoter Vector Source
pES28 CPY* ABCD GAL1 pTS210 Spear and Ng (2003)
pSK88 D1 ABCD GAL1 pTS210 This study
pSK89 D2 CD GAL1 pTS210 This study
pSK90 D3 ABD GAL1 pTS210 This study
pSK91 D4 ABCD GAL1 pTS210 This study
pSK92 D5 ABCD GAL1 pTS210 This study
pSK93 D6 ABCD GAL1 pTS210 This study
pSK95 CPY* aBCD GAL1 pTS210 This study
pSK96 CPY* AbCD GAL1 pTS210 This study
pSK97 CPY* ABcD GAL1 pTS210 This study
pSK94 CPY* abCD GAL1 pTS210 This study
pSK103 CPY* AbcD GAL1 pTS210 This study
pSK104 CPY* aBcD GAL1 pTS210 This study
pCH66 CPY* abcD GAL1 pTS210 Ling
pDN436 CPY* ABCD PRC1 pRS315 Ng et al. (2000)
pAS67 D1 ABCD PRC1 pRS316 This study
pAS63 D2 CD PRC1 pRS315 This study
pAS64 D3 ABD PRC1 pRS315 This study
pAS77 D4 ABCD PRC1 pRS315 This study
pAS68 D6 ABCD PRC1 pRS316 This study
doi:10.1371/journal.pone.0015532.t001
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Strain Genotype Source
W303a MATa, leu2-3,112, his3-11, trp1-1, ura3-1, can1-100, ade2-1 P.Walter (UCSF)
ESY258 MATa, pDN436, W303 background Spear and Ng, 2003
ESY259 MATa, cue1::TRP1, pDN436, W303 background Spear and Ng, 2003
ASY208 MATa, pAS67, W303 background This study
ASY209 MATa, cue1::TRP1, pAS67, W303 background This study
ASY202 MATa, pAS63, W303 background This study
ASY203 MATa, cue1::TRP1, pAS63, W303 background This study
ASY200 MATa, pAS64, W303 background This study
ASY201 MATa, cue1::TRP1, pAS64, W303 background This study
SKY204 MATa, pES28, W303 background This study
SKY226 MATa, pSK88, W303 background This study
SKY227 MATa, pSK89, W303 background This study
SKY228 MATa, pSK90, W303 background This study
SKY229 MATa, pSK91, W303 background This study
SKY230 MATa, pSK92, W303 background This study
SKY231 MATa, pSK93, W303 background This study
SKY249 MATa, pSK95, W303 background This study
SKY250 MATa, pSK96, W303 background This study
SKY251 MATa, pSK97, W303 background This study
SKY255 MATa, pSK94, W303 background This study
SKY265 MATa, pSK103, W303 background This study
SKY267 MATa, pSK104, W303 background This study
CHY535 MATa, pCH66, W303 background This study
SKY232 MATa, pep4::HIS3, pES28, W303 background This study
SKY233 MATa, pep4::HIS3, pCH66, W303 background This study
SKY234 MATa, pep4::HIS3, pSK88, W303 background This study
SKY235 MATa, pep4::HIS3, pSK89, W303 background This study
SKY236 MATa, pep4::HIS3, pSK90, W303 background This study
SKY237 MATa, pep4::HIS3, pSK91, W303 background This study
SKY238 MATa, pep4::HIS3, pSK92, W303 background This study
SKY239 MATa, pep4::HIS3, pSK93, W303 background This study
SKY252 MATa, pep4::HIS3, pSK95, W303 background This study
SKY253 MATa, pep4::HIS3, pSK96, W303 background This study
SKY254 MATa, pep4::HIS3, pSK97, W303 background This study
SKY256 MATa, pep4::HIS3, pSK94, W303 background This study
SKY266 MATa, pep4::HIS3, pSK103, W303 background This study
SKY268 MATa, pep4::HIS3, pSK104, W303 background This study
SKY240 MATa, hrd1::KANMX, pES28, W303 background This study
SKY242 MATa, hrd1::KANMX, pSK88, W303 background This study
SKY243 MATa, hrd1::KANMX, pSK89, W303 background This study
SKY244 MATa, hrd1::KANMX, pSK90, W303 background This study
SKY245 MATa, hrd1::KANMX, pSK91, W303 background This study
SKY246 MATa, hrd1::KANMX, pSK92, W303 background This study
SKY247 MATa, hrd1::KANMX, pSK93, W303 background This study
SKY398 MATa, cue1::TRP1, pES28, W303 background This study
SKY399 MATa, cue1::TRP1, pSK88, W303 background This study
SKY400 MATa, cue1::TRP1, pSK89, W303 background This study
SKY401 MATa, cue1::TRP1, pSK90, W303 background This study
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Cells containing GAL1 promoter regulated CPY* and its
variants were grown at 30uC in synthetic media containing the
appropriate amino acids and 3% raffinose to mid logarithmic
phase. Cell densities were adjusted to 0.1 OD600 units/ml. The
culture was diluted at 1:10 serially 4 times and 5 ml was taken from
each and spotted on SC plates containing 2% glucose (Glc) or 2%
galactose (Gal). Plates were incubated for 2 days at 30uC.
Supporting Information
Figure S1 Localization of CPY* deletion variants in wild
type and Dpep4 strains. Indirect immunofluorescence labeling
as described in Figure 1, panels B and C. This figure shows the
data set for wild type and all deletion constructs. The images
shown in Figure 1 are included here to simplify viewing.
Arrowheads show positions of substrate proteins localized in
vacuoles.
(TIF)
Figure S2 In vitro vesicle budding assays of CPY*
deletion and glycan mutants. (A) Representative immuno-
blots of data presented in Figure 3A. (B) Representative
immunoblots of data presented in Figure 5A. The COPII vesicle
membrane protein Erv25p is detected as a positive control for
vesicle budding in each experiment (23).
(TIF)
Figure S3 Relative expression levels of CPY* variants in
wild-type cells. (A) CPY* and deletion variants were expressed
in wild type cells for 6 h following galactose induction. Protein
extracts from each strain were separated by SDS-PAGE and
transferred onto a nitrocellulose membrane. Substrate proteins
were detected using anti-HA antibody. Visualization was per-
formed using fluorescent secondary antibodies as described in
Materials and Methods. The detection of Sec61p on the same
membrane was used as a loading control. The positions of
molecular weight markers are indicated. (B) CPY* and glycan
variants were analyzed as described in panel A.
(TIF)
Figure S4 Substrate toxicity in ERAD mutants. Dcue1 and
Dhrd1 cells carrying CPY* and deletion variant genes were grown
overnight in culture medium containing 3% raffinose. Each
culture was spotted onto agar plates as serial dilutions as described
in Figure 3C.
(TIF)
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